Exosome gel successfully treats acne


Regeneus, a clinical-stage regenerative medicine company, today announced that topical use of Sygenus gel for 6 weeks in adults with acne was well tolerated and showed a significant effect on the appearance of acne lesions as early as 3 weeks. ...

Read More »

New study demonstrates the potential of NX Prenatal blood-based biomarker panel to identify risk of premature birth as early as week 10 of pregnancy

exosome rna

LOUISVILLE, Ky.March 22, 2016 – NX Prenatal, Inc. announced today that the American Journal of Obstetrics and Gynecology (“AJOG”) published a manuscript entitled, “Evaluation of proteomic biomarkers associated with circulating microparticles as an effective means to stratify the risk of spontaneous ...

Read More »